Lonza Group Ltd. Expands Bioreactor Capacities At UK Plant; Will Invest 14 Million Swiss Francs ($11 Million) 
10/19/2005 5:09:19 PM

ZURICH, June 21 (Reuters) - Lonza (LONN.VX: Quote, Profile, Research) will invest 14 million Swiss francs ($11 million) at a southern England plant to expand production capacities there, the specialty chemicals firm said on Tuesday. Lonza said it would install another 500-litre bioreactor and two purification suites at the facility in Slough. The additional fermentation capacity would be on line in the fourth quarter of 2006. Lonza, which supplies ingredients for drugs to pharmaceutical companies, has already expanded its bioreactor capacity in the United States and said earlier this year it would build a commercial-scale biopharmaceutical facility in Switzerland.